Back to Results
First PageMeta Content



PRESS RELEASE – PRESSEINFORMATION GANYMED raises EUR 14.4 million in Series B Financing Round Mainz, Germany (July 06, 2005) – GANYMED Pharmaceuticals AG, a privately held antibody development company with a focus o
Add to Reading List

Document Date: 2015-02-04 05:15:01


Open Document

File Size: 45,77 KB

Share Result on Facebook